Enhabit, Inc. EHAB
At closeMay 14, 2026, 4:00 PM EDT
After hours · May 14, 4:00 PM ET
52-week range unavailable
- YTD
- +49.67%
- 1 year
- +30.43%
- Market cap
- 384.67M
- Revenue (ttm)
- 1.04B
- Profit margin
- -11.24%
- Shares out
- 50.28M
- Forward P/E
- 27.32
- YTD return
- +49.67%
- 1-year return
- +30.43%
- Volume
- 652.85K
- Open
- 13.79
- Previous close
- 13.80
- Day's range
- 13.79 – 13.81
- Beta
- 1.38
- Analysts
- Hold
- Price target
- 8.90 (-35.5%)
- Earnings date
- Aug 6, 2024
2Y 0.00 (0.00%)
Key statistics
- Enterprise value
- 952.87M
- PEG ratio
- 0.00
- Price / sales
- 0.37
- Price / book
- 0.68
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -1.80%
- Free cash flow
- 57.33M
- Total cash
- 45.70M
- Total debt
- 582.10M
- Return on equity
- -17.46%
- Short % of float
- 3.99%
- 50-day average
- 7.63
- 200-day average
- 8.82
Analyst view
Consensus: hold
- Target (low)
- 8.00
- Target (mean)
- 8.90
- Target (high)
- 10.00
- Strong buy0
- Buy1
- Hold5
- Sell0
- Strong sell0
Next earnings
Aug 6, 2024
Expected Aug 6, 2024. Consensus EPS estimate 0.05491.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | 0.04 | 0.03 | -0.01 | -25.00% |
| Aug 6, 2024 | Jun 1, 2024 | 0.06 | — | — | — |
| Aug 6, 2024 | Jun 1, 2024 | 0.06 | 0.07 | +0.01 | +16.67% |
| May 8, 2024 | Mar 1, 2024 | 0.05 | 0.07 | +0.02 | +40.00% |
| May 8, 2024 | Mar 1, 2024 | 0.05 | — | — | — |
| Mar 6, 2024 | Dec 1, 2023 | 0.02 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 9, 2024 | Jefferies | up | Hold | Buy |
| Nov 19, 2024 | Leerink Partners | reit | Market Perform | Market Perform |
| Jun 27, 2024 | B of A Securities | main | Underperform | Underperform |
| May 14, 2024 | Leerink Partners | up | Underperform | Market Perform |
| May 9, 2024 | Jefferies | down | Buy | Hold |
| Mar 11, 2024 | TD Cowen | main | Market Perform | Market Perform |
About Enhabit, Inc.
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- ehab.com
News
Jana Partners Buys Stake in Data Center Stock Everpure, May Be Up Almost 100% Already 
Enhabit Home Health & Hospice Announces New Chief Executive Officer 
Fast-paced Momentum Stock Enhabit (EHAB) Is Still Trading at a Bargain 
Enhabit (EHAB) Upgraded to Buy: Here's Why 
Centers For Medicare & Medicaid Services Announces Six-Month Moratoria On Hospice And Home Health Agency Registrations, Citing Fraud Crackdown 
Enhabit, Inc. (NYSE:EHAB) Receives Consensus Rating of “Hold” from Brokerages 
Are CCO, EHAB, APLS, VRE Obtaining Fair Deals for their Shareholders? 
Enhabit Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enhabit, Inc. - EHAB 
Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook 
JPMorgan Chase & Co. Sells 271,731 Shares of Enhabit, Inc. $EHAB
Your note
Sign in to keep a note on EHAB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOLTON JEFFREY | Director | Purchase | Dec 11, 2024 | 98,144 |
| BROWN-STEVENSON TINA L. | Director | Stock Award(Grant) | Jul 24, 2024 | 36,925 |
| CARLISLE CRISSY BUCHANAN | Chief Financial Officer | Stock Award(Grant) | Feb 29, 2024 | 88,342 |
| ELSON CHARLES M | Director | Stock Award(Grant) | Oct 9, 2024 | 51,982 |
| HOEFLINGER ERIN P | Director | Stock Award(Grant) | Oct 9, 2024 | 48,313 |
| JACOBSMEYER BARBARA ANN | Chief Executive Officer | Stock Award(Grant) | Feb 29, 2024 | 470,985 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 9.94% | 4,997,746 | 38.23M | Sep 29, 2024 |
| Blackrock Inc. | 7.83% | 3,935,169 | 30.10M | Sep 29, 2024 |
| 8 Knots Management, LLC | 7.57% | 3,807,296 | 29.13M | Sep 29, 2024 |
| Vanguard Group Inc | 5.92% | 2,976,480 | 22.77M | Sep 29, 2024 |
| Arex Capital Management, Lp | 4.86% | 2,441,921 | 18.68M | Sep 29, 2024 |
| Jana Partners Management, Lp | 4.25% | 2,137,145 | 16.35M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.16% | 1,591,459 | 12.17M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.47% | 1,242,379 | 9.50M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.57% | 790,754 | 6.05M | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 1.13% | 566,007 | 4.33M | Aug 30, 2024 |
| Fidelity Small Cap Index Fund | 1.01% | 507,000 | 3.88M | Aug 30, 2024 |
| DFA U.S. Targeted Value Portfolio | 0.90% | 452,197 | 3.46M | Jul 30, 2024 |